Artal Group S.A. Roivant Sciences Ltd. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$9.76 - $13.19 $6.1 Million - $8.24 Million	-625,000 Reduced 38.46%	1,000,000 $11.7 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $7.27 Million - $10.3 Million	1,025,000 Added 170.83%	1,625,000 $16.4 Million
Q1 2023 May 12, 2023	BUY	$6.92 - $9.98 $4.15 Million - $5.99 Million	600,000 New	600,000 $4.43 Million

314

495M

1.29M

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.28B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.